Skip to main content

Gamida Cell Ltd.

GMDADelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001600847

Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding Gamida Cell Ltd. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of GMDA: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders6255−7
Shares23.5M22.7M−835.8K (−3.6%)
Value$38.3M$29.1M−$9.18M (−24.0%)

New holders (14)

Institutions that held Gamida Cell Ltd. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to GMDA in Q4 2022
InstitutionSharesValue% of portfolio
FNY Investment Advisers, LLC153,000$197.0K0.28%
Ergoteles LLC74,032$95.5K0.00%
Credit Suisse AG47,500$61.3K0.00%
Kapitalo Investimentos Ltda43,900$56.6K0.04%
Jane Street Group, LLC25,508$32.9K0.00%
TrinityPoint Wealth, LLC20,000$25.8K0.01%
Cambridge Investment Research Advisors, Inc.19,075$25.0K0.00%
Millennium Management LLC16,602$21.0K0.00%
Meritage Portfolio Management13,000$17.0K0.00%
Engineers Gate Manager LP11,421$14.7K0.00%
Quent Capital, LLC1,522$1.96K0.00%
Belpointe Asset Management LLC1,000$1.29K0.00%
UBS Group AG325$4190.00%
CIBC Private Wealth Group, LLC14,620$190.00%

Sold out (21)

Institutions that held Gamida Cell Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.